Imidazole → HCID 20138061, compound
Reaction equation
Cl[CH2:2][CH2:3][CH:4]1[CH2:10][N:9]([CH3:11])[C:8](=[O:12])[C:7]2[CH:13]=[CH:14][CH:15]=[N:16][C:6]=2[CH2:5]1.[NH:17]1[CH:21]=[CH:20][N:19]=[CH:18]1>CN(C)C=O>[N:17]1([CH2:2][CH2:3][CH:4]2[CH2:10][N:9]([CH3:11])[C:8](=[O:12])[C:7]3[CH:13]=[CH:14][CH:15]=[N:16][C:6]=3[CH2:5]2)[CH:21]=[CH:20][N:19]=[CH:18]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 130 °C
Procedure
To a solution of 8-(2-chloroethyl)-6,7,8,9-tetrahydro-6-methyl-5H-pyrido[3,2-c]azepin-5-one in dimethylformamide (DMF) is added imidazole. The solution is heated to about 130° C. for several hr. DMF is removed by evaporation in vacuo and the residue is taken up in chloroform. The chloroform solution is washed with dilute aqueous sodium hydroxie, dried over anhydrous sodium sulfate and concentrated on a rotary evaporator to give the title compound.
Workup
- customDMF is removed by evaporation in vacuo
- washThe chloroform solution is washed with dilute aqueous sodium hydroxie
- dry with materialdried over anhydrous sodium sulfate
- concentrationconcentrated on a rotary evaporator
Sources & evidence
- ORD record
- ord-aede4aefc7e6417286769128a19a0fdb
- Source dataset
- uspto-grants-1988_05
- Patent number
- US04746657
Reaction notes
Loading…